Bioelectrix - REACH

Important results from the project

The objective of the project was fully achieved. Bioelectrix participated in REACH at Palo Alto and strengthened its understanding of the US market, especially in medtech, clinical adoption, partnerships, sales, pricing and investor communications. The project provided important contacts, clinical input and two valuable partnership meetings.

Expected long term effects

In the longer term, the project is expected to reduce the risk for Bioelectrix´s future establishment in the US market. The company has gained a clearer picture of which actors are important, which obstacles need to be addressed, and how the technology should be positioned for clinical adoption, partnerships, and future commercialization.

Approach and implementation

The project was implemented through a preparatory online phase and two weeks on-site in Palo Alto, April 20 to May 1. Bioelectrix participated in workshops, mentoring, pitch training, investor panel, Stanford visit and meetings with strategic and clinical contacts. The activities were relevant and the project was implemented according to plan